Pfizer Inc. on Tuesday posted a higher third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales.
The maker of cholesterol fighter Lipitor, impotence treatment Viagra and smoking cessation drug Chantix slashed costs on everything from manufacturing and marketing to research and development to produce a profit of $2.88 billion. That was up 26 percent from $2.28 billion a year earlie
Oct 20 · 12:24:00 PM · Source: AP
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
COMMENTS:
Advertisement